Six virtual mobility collaborations have led to the achievement of many objectives of GYNOCARE COST Action.
These resulted in a harmonised classification of rare gynae cancers, with the input of important stakeholders from the RARECAREnet, European Board and College of Obstetricians and Gynaecologists (EBCOG) and IARC/WHO. Three surveys have been designed thanks to these virtual mobilities, which are about to receive ethics approval and then will be sent out to the members of the COST, as well as to other participants affiliated to EBCOG and other international networks. Another survey has been designed on the effect of the COVID-19 pandemic on the management of gynaecological malignancies, and the impact especially on rare gynae cancers. In total, there were more than 15 separate virtual meetings of approximately 2 hours each, involving more than 10 members from 5 COST countries.
Here is a list of the virtual mobility collaborative activities which have been successfully carried out during 2021:
Compilation of a comprehensive integrated classification for rare gynae cancers
VM grant start and end date: 01/10/2021 to 21/10/2021
Grantee name: Dr Miriam Azzopardi
The VM grant report can be viewed here:
VM grant report - Dr Miriam Azzopardi
Creation of a standard template for cancer registries for rare gynaecological malignancies
VM grant start and end date: 20/9/2021 to 20/10/2021
Grantee name: Ms Rita Micallef
The VM grant report can be viewed here:
VM grant report - Ms Rita Micallef
The presentation of this VM given at the Managment Committee meeting on the 26th October 2021 can be viewed here:
VM presentation - Ms Rita Micallef
Harmonising a common dataset for biobanking of rare gynaecological cancers
VM grant start and end date: 13/9/2021 to 18/10/2021
Grantee name: Dr Sharon O’Toole
The VM grant report can be viewed here:
VM grant report - Dr Sharon O'Toole
The presentation of this VM given at the Managment Committee meeting on the 26th October 2021 can be viewed here:
Presentation of VM - Dr Sharon O'Toole
Documentation of the Process of Informed Consent for biobanking of rare gynaecological tumours.
VM grant start and end date: 18/09/2021 to 18/10/2021
Grantee name: Dr Bridget Ellul
The VM grant report can be viewed here:
Virtual Mobility Report - Dr Bridget Ellul
The presentation of this VM given at the Managment Committee meeting on the 26th October 2021 can be viewed here:
VM presentation Dr Bridget Ellul
Biobanking of Rare Gynaecological Tumours: The Legal Aspects
VM grant start and end date: 04/10/2021 to 24/10/2021
Grantee name: Dr Olga Tzortzatou
The VM grant report can be viewed here:
Virtual Mobility Report - Dr Olga Tzortzatou
Impact of COVID-19 on Management of Gynaecological Cancers
VM grant start and end date: 15/09/2021 to 20/10/2021
Grantee name: Dr Riccardo Di Fiore
The VM grant report can be viewed here:
VM-grant-report and Survey Covid-19_RICCARDO DI FIORE (1)
The presentation of this VM given at the Management Committee meeting on the 26th October 2021 can be viewed here:
VM Riccardo Di Fiore GYNOCARE Meeting 26.10.21
